Glucose Control in Sepsis |
패혈증에서의 혈당 조절 |
김성집ㆍ조항주 |
Division of Trauma Surgery, Uijongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijongbu, Korea |
|
Abstract |
Traditionally stress hyperglycemia was considered to be a adaptive response, with raised blood glucose providing a fuel for the brain, skeletal muscle, heart and other vital organs. In 2001, intensive insuline therapy (IIT) that demonstrated a survival benefit in surgical critical care led to clinicians to control glucose within tight range (<110 mg/dl). However, randomized controlled studies including NICE-SUGAR study have shown IIT was no survival benefit compared with conventional therapy (CT). Now, controlling blood glucose within 140∼180 mg/dl in sepsis patients is accepted as reasonable range because IIT was related with frequent hypoglycemic events and no survival benefit compared with CT. (J Surg Crit Care 2013;3:18-21) |
Key Words:
Sepsis, Glucose control, ICU |
|